Providing the most up-to-date, complete and innovative injectable drug compatibility and stability information in hospital pharmacy worldwide, the King Guide is a proven, authoritative resource for pharmacists, nurses, physicians and other practitioners involved in the preparation and administration of intravenous drugs.
"This is the most updated information on parenteral admixtures on the market."
IJPC Vol.5 No.4 July/August 2001.
Features
In this update we added a new monograph for APREPITANT.
We also added new stability information to the monographs for CABAZITAXEL, FOSAPREPITANT DIMEGLUMINE, OMADACYCLINE, and PEMBROLIZUMAB.
New compatibility information was added to the existing drug monographs for COLISTIMETHATE SODIUM, AZTREONAM, CEFOTAXIME SODIUM, CEFTRIAXONE, CO-TRIMOXAZOLE, DAPTOMYCIN, FLUCONAZOLE, FUROSEMIDE, HEPARIN SODIUM, HYDROCORTISONE SODIUM SUCCINATE, IBUPROFEN, INSULIN, REGULAR, KETOPROFEN, LEVETIRACETAM, LINEZOLID, MAGNESIUM SULFATE, MORPHINE SULFATE, NAFCILLIN SODIUM, OMADACYCLINE, ONDANSETRON HYDROCHLORIDE, PALONOSETRON HYDROCHLORIDE, PIPERACILLIN AND TAZOBACTAM, POTASSIUM CHLORIDE, POTASSIUM PHOSPHATE, PROTAMINE SULFATE, SODIUM PHOSPHATE, TENECTEPLASE, THIAMINE HYDROCHLORIDE and TRAMADOL HYDROCHLORIDE.